Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Ductal, Breast | 2 | 2024 | 1083 | 1.040 |
Why?
|
Immunotherapy | 5 | 2022 | 4594 | 0.900 |
Why?
|
Prisoners | 2 | 2023 | 296 | 0.860 |
Why?
|
Antigens, Surface | 9 | 2005 | 1607 | 0.860 |
Why?
|
Inflammatory Breast Neoplasms | 1 | 2024 | 144 | 0.830 |
Why?
|
Immunoglobulin Class Switching | 1 | 2024 | 290 | 0.830 |
Why?
|
Students, Medical | 3 | 2023 | 1875 | 0.750 |
Why?
|
Plasma Cells | 1 | 2024 | 589 | 0.740 |
Why?
|
Cultural Diversity | 1 | 2023 | 342 | 0.700 |
Why?
|
Cyclonic Storms | 1 | 2021 | 117 | 0.700 |
Why?
|
Carcinoma, Lobular | 1 | 2024 | 490 | 0.690 |
Why?
|
Job Description | 1 | 2019 | 61 | 0.680 |
Why?
|
Interleukins | 1 | 2024 | 772 | 0.670 |
Why?
|
Internship and Residency | 4 | 2024 | 5763 | 0.660 |
Why?
|
Terrorism | 1 | 2021 | 210 | 0.610 |
Why?
|
Immunoglobulin E | 1 | 2024 | 1491 | 0.600 |
Why?
|
Faculty, Medical | 2 | 2023 | 1169 | 0.600 |
Why?
|
Physicians, Women | 1 | 2023 | 466 | 0.590 |
Why?
|
Leadership | 2 | 2023 | 1352 | 0.580 |
Why?
|
Clinical Clerkship | 1 | 2023 | 559 | 0.570 |
Why?
|
Specialties, Surgical | 1 | 2021 | 381 | 0.560 |
Why?
|
Mentors | 1 | 2022 | 650 | 0.550 |
Why?
|
Emigrants and Immigrants | 1 | 2023 | 530 | 0.540 |
Why?
|
Breast Neoplasms | 5 | 2024 | 20754 | 0.540 |
Why?
|
Disasters | 1 | 2021 | 496 | 0.520 |
Why?
|
Disaster Planning | 1 | 2021 | 555 | 0.520 |
Why?
|
Semantics | 1 | 2019 | 599 | 0.510 |
Why?
|
Terminology as Topic | 2 | 2020 | 1529 | 0.510 |
Why?
|
Radiology, Interventional | 1 | 2019 | 471 | 0.510 |
Why?
|
Tissue and Organ Procurement | 1 | 2023 | 889 | 0.490 |
Why?
|
Neoplasms | 6 | 2024 | 21681 | 0.490 |
Why?
|
Laparoscopy | 2 | 2024 | 2147 | 0.480 |
Why?
|
Specialization | 1 | 2019 | 767 | 0.480 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2024 | 2254 | 0.470 |
Why?
|
Education, Medical, Undergraduate | 1 | 2023 | 1044 | 0.460 |
Why?
|
Immunoglobulin G | 1 | 2024 | 4480 | 0.410 |
Why?
|
Medicine | 1 | 2020 | 930 | 0.410 |
Why?
|
Liver Neoplasms | 3 | 2024 | 4247 | 0.390 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2011 | 155 | 0.370 |
Why?
|
General Surgery | 1 | 2021 | 1622 | 0.360 |
Why?
|
Sirtuin 1 | 1 | 2011 | 244 | 0.350 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2011 | 4518 | 0.330 |
Why?
|
Molecular Targeted Therapy | 2 | 2019 | 2777 | 0.300 |
Why?
|
Immunologic Factors | 1 | 2017 | 1568 | 0.300 |
Why?
|
Southeastern United States | 2 | 2024 | 87 | 0.300 |
Why?
|
Cell Differentiation | 3 | 2024 | 11385 | 0.290 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7272 | 0.280 |
Why?
|
Interleukin-18 | 1 | 2008 | 241 | 0.280 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2011 | 1173 | 0.280 |
Why?
|
United States | 12 | 2024 | 70368 | 0.270 |
Why?
|
Humans | 44 | 2024 | 746070 | 0.270 |
Why?
|
Career Choice | 2 | 2023 | 743 | 0.270 |
Why?
|
Blood Proteins | 5 | 2004 | 1151 | 0.270 |
Why?
|
Schools, Medical | 2 | 2022 | 868 | 0.250 |
Why?
|
Interferon-gamma | 5 | 2008 | 3134 | 0.250 |
Why?
|
Mastectomy, Modified Radical | 1 | 2024 | 62 | 0.240 |
Why?
|
Prisons | 2 | 2023 | 160 | 0.240 |
Why?
|
Apoptosis Regulatory Proteins | 9 | 2005 | 1138 | 0.230 |
Why?
|
Receptors, Lysophosphatidic Acid | 2 | 2014 | 76 | 0.230 |
Why?
|
T-Lymphocytes | 7 | 2019 | 10018 | 0.210 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2018 | 5280 | 0.210 |
Why?
|
Peptides | 7 | 2008 | 4312 | 0.200 |
Why?
|
Genetic Loci | 1 | 2011 | 2554 | 0.200 |
Why?
|
Palatine Tonsil | 1 | 2002 | 189 | 0.200 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 25174 | 0.200 |
Why?
|
Police | 2 | 2022 | 152 | 0.200 |
Why?
|
Immunologic Memory | 1 | 2008 | 1331 | 0.190 |
Why?
|
Melanoma, Experimental | 1 | 2004 | 553 | 0.190 |
Why?
|
Pandemics | 4 | 2022 | 8434 | 0.190 |
Why?
|
Synovial Membrane | 2 | 2014 | 521 | 0.190 |
Why?
|
Neoplasms, Experimental | 2 | 2004 | 1226 | 0.180 |
Why?
|
Metaphor | 1 | 2020 | 40 | 0.180 |
Why?
|
Immune Tolerance | 4 | 2013 | 2215 | 0.180 |
Why?
|
Interleukin-4 | 1 | 2024 | 1101 | 0.180 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2004 | 1800 | 0.180 |
Why?
|
rap GTP-Binding Proteins | 1 | 2019 | 24 | 0.170 |
Why?
|
Genetic Counseling | 1 | 2023 | 611 | 0.170 |
Why?
|
Antineoplastic Agents | 4 | 2017 | 13531 | 0.170 |
Why?
|
Policy | 1 | 2023 | 502 | 0.160 |
Why?
|
Retrospective Studies | 7 | 2024 | 78293 | 0.160 |
Why?
|
Altruism | 1 | 2020 | 202 | 0.160 |
Why?
|
Female | 19 | 2024 | 382129 | 0.160 |
Why?
|
Epigenesis, Genetic | 1 | 2011 | 3655 | 0.150 |
Why?
|
New York | 1 | 2020 | 868 | 0.150 |
Why?
|
Lymph Node Excision | 1 | 2024 | 1277 | 0.150 |
Why?
|
Genital Neoplasms, Female | 1 | 2023 | 525 | 0.150 |
Why?
|
Fibronectins | 2 | 2019 | 724 | 0.150 |
Why?
|
Lung Neoplasms | 3 | 2018 | 13196 | 0.150 |
Why?
|
Adenoma, Pleomorphic | 1 | 2018 | 75 | 0.150 |
Why?
|
Virus Diseases | 1 | 2003 | 722 | 0.140 |
Why?
|
Healthcare Disparities | 2 | 2024 | 3204 | 0.140 |
Why?
|
Mastectomy, Segmental | 1 | 2022 | 956 | 0.140 |
Why?
|
Solubility | 1 | 2018 | 1089 | 0.130 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1656 | 0.130 |
Why?
|
Cell Proliferation | 4 | 2015 | 10303 | 0.130 |
Why?
|
Animals | 20 | 2024 | 166308 | 0.130 |
Why?
|
Glycosylation | 1 | 2018 | 1077 | 0.120 |
Why?
|
Mice | 15 | 2024 | 80065 | 0.120 |
Why?
|
Signal Transduction | 7 | 2020 | 23115 | 0.120 |
Why?
|
Receptors, Notch | 1 | 2019 | 734 | 0.120 |
Why?
|
Fibroblasts | 2 | 2014 | 4039 | 0.120 |
Why?
|
Guideline Adherence | 1 | 2024 | 2188 | 0.110 |
Why?
|
Movement | 1 | 2021 | 1464 | 0.110 |
Why?
|
Dopamine | 1 | 2020 | 1571 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 3782 | 0.110 |
Why?
|
Nephritis, Interstitial | 1 | 2014 | 155 | 0.110 |
Why?
|
Students | 1 | 2023 | 1634 | 0.110 |
Why?
|
Antigens, CD | 8 | 2008 | 3898 | 0.110 |
Why?
|
Zebrafish Proteins | 1 | 2019 | 997 | 0.110 |
Why?
|
Male | 13 | 2024 | 351098 | 0.100 |
Why?
|
Cell Adhesion | 1 | 2019 | 3089 | 0.100 |
Why?
|
Dendritic Cells | 3 | 2015 | 2709 | 0.100 |
Why?
|
Organoplatinum Compounds | 1 | 2014 | 403 | 0.100 |
Why?
|
Lysophospholipids | 1 | 2014 | 339 | 0.100 |
Why?
|
Antibodies, Monoclonal | 6 | 2017 | 9103 | 0.100 |
Why?
|
Reoperation | 1 | 2022 | 4215 | 0.100 |
Why?
|
Protein Transport | 1 | 2018 | 1962 | 0.100 |
Why?
|
Anxiety Disorders | 1 | 2023 | 2678 | 0.100 |
Why?
|
Membrane Glycoproteins | 6 | 2005 | 3661 | 0.100 |
Why?
|
Antibodies | 2 | 2018 | 2408 | 0.100 |
Why?
|
Cisplatin | 2 | 2015 | 1637 | 0.090 |
Why?
|
Liver | 2 | 2004 | 7371 | 0.090 |
Why?
|
Arthritis, Experimental | 1 | 2013 | 288 | 0.090 |
Why?
|
Motor Activity | 1 | 2020 | 2666 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2023 | 1771 | 0.090 |
Why?
|
Genetic Testing | 1 | 2023 | 3480 | 0.090 |
Why?
|
Minor Histocompatibility Antigens | 2 | 2008 | 294 | 0.090 |
Why?
|
Blotting, Western | 1 | 2018 | 5048 | 0.090 |
Why?
|
Wnt Proteins | 1 | 2014 | 719 | 0.090 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2010 | 48 | 0.090 |
Why?
|
Medical Oncology | 1 | 2022 | 2269 | 0.090 |
Why?
|
Attitude of Health Personnel | 1 | 2024 | 3820 | 0.090 |
Why?
|
Curriculum | 1 | 2023 | 3621 | 0.090 |
Why?
|
Communication | 1 | 2024 | 3783 | 0.090 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2015 | 711 | 0.090 |
Why?
|
Pilot Projects | 1 | 2023 | 8370 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2015 | 5164 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 3896 | 0.080 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2010 | 143 | 0.080 |
Why?
|
Interleukin-12 | 1 | 2011 | 577 | 0.080 |
Why?
|
Acetylation | 1 | 2011 | 1046 | 0.080 |
Why?
|
Cytokines | 4 | 2014 | 7219 | 0.080 |
Why?
|
Adult | 7 | 2024 | 214969 | 0.080 |
Why?
|
Immune System | 1 | 2013 | 800 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 3011 | 0.080 |
Why?
|
Lectins, C-Type | 2 | 2008 | 584 | 0.080 |
Why?
|
NAD | 1 | 2011 | 594 | 0.070 |
Why?
|
Middle Aged | 6 | 2024 | 214419 | 0.070 |
Why?
|
B-Lymphocytes | 3 | 2013 | 4671 | 0.070 |
Why?
|
Aged | 8 | 2024 | 164222 | 0.070 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5236 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3214 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 1 | 2019 | 3345 | 0.070 |
Why?
|
Protein Multimerization | 1 | 2011 | 965 | 0.070 |
Why?
|
Lymphocyte Depletion | 1 | 2008 | 588 | 0.070 |
Why?
|
Case-Control Studies | 1 | 2024 | 21676 | 0.070 |
Why?
|
Antigens, Differentiation | 3 | 2004 | 846 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 3 | 2014 | 3730 | 0.070 |
Why?
|
Mice, Knockout | 4 | 2013 | 14212 | 0.070 |
Why?
|
Prognosis | 2 | 2024 | 29072 | 0.070 |
Why?
|
Protein Binding | 1 | 2018 | 9280 | 0.060 |
Why?
|
Mice, Transgenic | 3 | 2008 | 9441 | 0.060 |
Why?
|
Pain | 1 | 2020 | 4980 | 0.060 |
Why?
|
Adenosine Triphosphate | 1 | 2011 | 1980 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2024 | 38752 | 0.060 |
Why?
|
Lymphocyte Activation | 3 | 2004 | 5414 | 0.060 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2010 | 973 | 0.060 |
Why?
|
Transfection | 2 | 2002 | 5786 | 0.060 |
Why?
|
Salivary Glands | 1 | 2005 | 225 | 0.060 |
Why?
|
Interleukin-17 | 1 | 2010 | 891 | 0.060 |
Why?
|
Sjogren's Syndrome | 1 | 2005 | 234 | 0.060 |
Why?
|
Autoantigens | 1 | 2008 | 868 | 0.060 |
Why?
|
Proteins | 3 | 2003 | 6000 | 0.060 |
Why?
|
Kupffer Cells | 1 | 2003 | 143 | 0.050 |
Why?
|
Antibodies, Blocking | 1 | 2003 | 231 | 0.050 |
Why?
|
Clonal Anergy | 1 | 2003 | 168 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3054 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3166 | 0.050 |
Why?
|
Receptors, Cell Surface | 2 | 2008 | 2820 | 0.050 |
Why?
|
Self Tolerance | 1 | 2002 | 121 | 0.050 |
Why?
|
Tumor Escape | 1 | 2004 | 364 | 0.050 |
Why?
|
Mice, Inbred DBA | 1 | 2002 | 608 | 0.050 |
Why?
|
Propaganda | 1 | 2020 | 7 | 0.050 |
Why?
|
Synovial Fluid | 1 | 2003 | 391 | 0.050 |
Why?
|
Histones | 1 | 2011 | 2552 | 0.050 |
Why?
|
Bone Marrow Cells | 2 | 2013 | 2412 | 0.050 |
Why?
|
Prescriptions | 1 | 2023 | 382 | 0.050 |
Why?
|
Indocyanine Green | 1 | 2022 | 233 | 0.050 |
Why?
|
Lymphoid Tissue | 1 | 2002 | 448 | 0.050 |
Why?
|
Mice, Inbred C57BL | 5 | 2013 | 21529 | 0.050 |
Why?
|
Insulin-Secreting Cells | 1 | 2008 | 892 | 0.050 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2002 | 887 | 0.050 |
Why?
|
Ki-67 Antigen | 1 | 2002 | 635 | 0.040 |
Why?
|
Rats, Long-Evans | 1 | 2020 | 371 | 0.040 |
Why?
|
Germinal Center | 1 | 2002 | 379 | 0.040 |
Why?
|
Mice, Inbred BALB C | 3 | 2002 | 6091 | 0.040 |
Why?
|
Kidney | 1 | 2014 | 6984 | 0.040 |
Why?
|
Faculty | 1 | 2022 | 379 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2015 | 4846 | 0.040 |
Why?
|
Tumor Cells, Cultured | 2 | 2002 | 6138 | 0.040 |
Why?
|
Child | 2 | 2023 | 78469 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 9524 | 0.040 |
Why?
|
Aftercare | 1 | 2023 | 892 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5609 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2014 | 11842 | 0.030 |
Why?
|
Mice, Nude | 1 | 2002 | 3576 | 0.030 |
Why?
|
Violence | 1 | 2022 | 912 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2014 | 18891 | 0.030 |
Why?
|
Immunoconjugates | 1 | 2002 | 857 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2010 | 5746 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2004 | 2511 | 0.030 |
Why?
|
Propionates | 1 | 2014 | 177 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2022 | 1087 | 0.030 |
Why?
|
Isoxazoles | 1 | 2014 | 226 | 0.030 |
Why?
|
Colonic Neoplasms | 1 | 2004 | 2499 | 0.030 |
Why?
|
Cricetulus | 1 | 2014 | 817 | 0.030 |
Why?
|
CHO Cells | 1 | 2014 | 1393 | 0.020 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2015 | 554 | 0.020 |
Why?
|
Hemorrhage | 1 | 2023 | 3522 | 0.020 |
Why?
|
Osteoarthritis | 2 | 2013 | 1047 | 0.020 |
Why?
|
Cell Transplantation | 1 | 2013 | 470 | 0.020 |
Why?
|
Models, Immunological | 1 | 2013 | 506 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2003 | 4414 | 0.020 |
Why?
|
Graft vs Host Disease | 1 | 2003 | 2931 | 0.020 |
Why?
|
Cricetinae | 1 | 2014 | 2426 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3304 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2003 | 4296 | 0.020 |
Why?
|
Fluorouracil | 1 | 2015 | 1598 | 0.020 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2010 | 106 | 0.020 |
Why?
|
Osteoclasts | 1 | 2013 | 709 | 0.020 |
Why?
|
Acute Disease | 2 | 2014 | 7116 | 0.020 |
Why?
|
Benzamides | 1 | 2014 | 1341 | 0.020 |
Why?
|
Doxorubicin | 1 | 2015 | 2194 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4732 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10278 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2015 | 16652 | 0.020 |
Why?
|
Zebrafish | 1 | 2019 | 2980 | 0.020 |
Why?
|
Paclitaxel | 1 | 2015 | 1678 | 0.020 |
Why?
|
Spleen | 1 | 2013 | 2272 | 0.020 |
Why?
|
Fibrosis | 1 | 2014 | 2005 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4576 | 0.020 |
Why?
|
Quinazolines | 1 | 2014 | 1350 | 0.020 |
Why?
|
Th17 Cells | 1 | 2013 | 768 | 0.020 |
Why?
|
Gene Expression | 2 | 2014 | 7579 | 0.020 |
Why?
|
Actins | 1 | 2014 | 2051 | 0.020 |
Why?
|
Leukocytes | 1 | 2014 | 2010 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2010 | 1327 | 0.020 |
Why?
|
RNA Interference | 1 | 2015 | 2844 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2014 | 1853 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3443 | 0.020 |
Why?
|
Medicare | 1 | 2023 | 6541 | 0.020 |
Why?
|
Ligands | 2 | 2002 | 3266 | 0.020 |
Why?
|
Brain Mapping | 1 | 2020 | 6595 | 0.020 |
Why?
|
Cell Survival | 1 | 2015 | 5759 | 0.020 |
Why?
|
Multiple Myeloma | 1 | 2002 | 5101 | 0.010 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2010 | 811 | 0.010 |
Why?
|
Rats | 1 | 2020 | 23681 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2018 | 57552 | 0.010 |
Why?
|
Flow Cytometry | 2 | 2005 | 5837 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12632 | 0.010 |
Why?
|
Mice, Inbred NOD | 1 | 2008 | 1809 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2014 | 3025 | 0.010 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 2003 | 133 | 0.010 |
Why?
|
Perforin | 1 | 2003 | 169 | 0.010 |
Why?
|
Fas Ligand Protein | 1 | 2003 | 212 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 3609 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2008 | 1240 | 0.010 |
Why?
|
Cell Movement | 1 | 2014 | 5161 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8359 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2008 | 1338 | 0.010 |
Why?
|
Epitopes | 1 | 2008 | 2505 | 0.010 |
Why?
|
Transduction, Genetic | 1 | 2004 | 895 | 0.010 |
Why?
|
Time Factors | 1 | 2002 | 39589 | 0.010 |
Why?
|
Child, Preschool | 1 | 2002 | 41383 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2881 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 5761 | 0.010 |
Why?
|
Apoptosis | 1 | 2014 | 9425 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2003 | 1156 | 0.010 |
Why?
|
Risk Factors | 1 | 2023 | 72413 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2003 | 1868 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2010 | 7570 | 0.010 |
Why?
|
Down-Regulation | 1 | 2003 | 2906 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2003 | 2676 | 0.010 |
Why?
|
Lymphocytes | 1 | 2002 | 2589 | 0.010 |
Why?
|
Up-Regulation | 1 | 2004 | 4115 | 0.010 |
Why?
|
Autoimmunity | 1 | 2002 | 1332 | 0.010 |
Why?
|
Adolescent | 1 | 2002 | 86212 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2005 | 3658 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2002 | 2193 | 0.010 |
Why?
|